Printer Friendly

Second U.S. Patent issued to Skinvisible for polymer delivery vehicle.

* Skinvisible, Inc., a topical drug delivery company, announced that it has been issued a second patent by the U.S. Patent and Trademark Office protecting the 'Polymer Composition' of the Company's Invisicare polymer delivery system. When topically applied, Invisicare-formulated products hold active ingredients on the skin for up to four hours, thereby affording the active ingredients an extended timeframe to perform their intended functions.

Previously, a patent was issued to Skinvisible related to the 'Method of Manufacturing' Invisicare. A third patent application, related to 'Methods of Use' of Invisicare, is pending.

"The issuance of this second Invisicare patent protects the unique mechanism by which we can safely deliver formulated products using Invisicare to remain on the skin for extended periods of time, resulting in improved efficacy, longer duration of action, reduced irritation and lower dosage of active agent required. This patent thus represents another significant milestone for our company, one that continues to validate the novelty of our technology platform, Invisicare," said Terry Howlett, president and chief executive officer of Skinvisible.

COPYRIGHT 2006 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Industry News
Publication:Household & Personal Products Industry
Date:Feb 1, 2006
Words:171
Previous Article:P&G signs agreements with nanotech firms.
Next Article:P&G Professional launches the Dawn Arsenal for foodservice industry.
Topics:


Related Articles
Patent News.
Skinvisible announces agreement to sell its proprietary polymer.
Patent News.
LAM Pharmaceutical expands intellectual property assets.
Carrington announces patent issued for gel drug delivery system.
Carrington granted European patent for drug delivery technology.
Method for producing polymer coated pigments.
Carrington subsidiary DelSite granted Chinese patent on GelSite polymer technology for drugs and vaccines.
Carrington subsidiary DelSite granted Korean patent for GelSite polymer technology.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters